PSMF Maintenance and Change Control

A practical guide to PSMF maintenance, governance, review cycles, change management and long-term sustainability.

PSMF Maintenance and Change Control

Introduction

Creating a Pharmacovigilance System Master File is relatively straightforward.

Maintaining it accurately over time is far more difficult.

Many organisations begin with a high-quality document.

Over time, however, the pharmacovigilance system evolves:

Unless maintenance activities evolve at the same pace, the PSMF gradually becomes less accurate.

This process is often subtle.

The document may remain largely correct while becoming progressively less representative of operational reality.

For this reason, experienced inspectors often view PSMF maintenance as a governance issue rather than a documentation issue.

The Real Objective of Maintenance

Many organisations approach maintenance incorrectly.

They focus on:

Updating the document.

The actual objective is different.

The objective is:

Ensuring the PSMF continuously reflects the pharmacovigilance system.

This distinction is important.

The goal is not document compliance.

The goal is system representation.

A perfectly formatted PSMF that no longer reflects reality provides little regulatory value.

Why PSMFs Become Outdated

The most common causes include:

Rarely does a PSMF become inaccurate because of a single major failure.

More commonly, numerous small changes accumulate over time.

Examples include:

Individually these issues may appear minor.

Collectively they create inspection risk.

The PSMF Lifecycle

A useful way to view the PSMF is as a lifecycle rather than a document.

The lifecycle generally includes:

  1. Creation
  2. Review
  3. Approval
  4. Maintenance
  5. Verification
  6. Improvement

Many organisations invest heavily in stages 1–3.

The strongest organisations focus primarily on stages 4–6.

Ownership Models

One of the most important governance decisions concerns ownership.

Central Ownership Model

A single function owns the entire PSMF.

Advantages:

Challenges:

Distributed Ownership Model

Different sections have different owners.

Examples:

Section Owner
QPPV Information PV Governance
Product Inventory Regulatory Affairs
Vendor Inventory PV Operations
Audit Annex Quality Assurance
Systems Inventory IT / System Owner

Advantages:

Challenges:

Hybrid Model

Most mature organisations adopt a hybrid approach.

Central governance coordinates updates while subject matter experts maintain specific content.

Change Control and the PSMF

The strongest PSMF programmes are integrated into change control processes.

Whenever a significant change occurs, organisations should ask:

This transforms maintenance from a reactive activity into a proactive governance process.

Changes That Should Trigger Review

Examples include:

Organisational Changes

Personnel Changes

Vendor Changes

Product Changes

Technology Changes

Compliance Events

These events frequently require PSMF updates.

Review Frequencies

A common question is:

How often should a PSMF be reviewed?

There is no universally correct answer.

The appropriate frequency depends upon:

Typical approaches include:

Activity Typical Frequency
Annex review Monthly or Quarterly
Governance review Quarterly
Full PSMF review Annually
Change-triggered review As needed

The critical point is not frequency.

The critical point is effectiveness.

Annex Maintenance

Most maintenance effort involves annexes.

Commonly updated annexes include:

These sections often change far more frequently than the main body.

For additional information see:

[[psmf-annexes-guide]]

Maintaining Product Inventories

Product inventories often represent one of the largest maintenance burdens.

Common update triggers include:

Many organisations align inventory updates with Regulatory Affairs activities.

This improves consistency and reduces duplication.

Maintaining Vendor Inventories

Vendor inventories are another common source of findings.

Updates should occur when:

Strong organisations integrate vendor governance and PSMF governance.

The Role of Metrics

Metrics help prevent gradual deterioration.

Examples include:

Metrics convert maintenance from a subjective activity into an objective one.

For additional information see:

[[psmf-metrics]]

QPPV Oversight

The QPPV does not necessarily maintain the PSMF personally.

However, regulators generally expect visibility regarding:

The QPPV should have confidence that maintenance processes are functioning effectively.

For additional information see:

[[psmf-qppv-oversight]]

Inspection Perspective

Inspectors often review maintenance processes as carefully as the document itself.

Typical questions include:

Inspectors are often less interested in a single outdated entry than in the process that allowed it to occur.

Signs of a Mature Maintenance Programme

Characteristics commonly include:

Clear Ownership

Responsibilities are documented and understood.

Change Control Integration

Updates are linked to operational change.

Routine Reviews

Review activities occur consistently.

Metrics

Quality is monitored objectively.

Governance

Senior oversight exists.

Inspection Readiness

The document remains current throughout the year.

The Biggest Mistake Organisations Make

The most common mistake is treating the PSMF as a document.

The PSMF is not simply a document.

It is a representation of the pharmacovigilance system.

When organisations focus exclusively on document maintenance, quality gradually deteriorates.

When organisations focus on maintaining alignment between the document and the system, quality tends to improve naturally.

Key Takeaways

References

  1. EMA Good Pharmacovigilance Practices (GVP) Module II – Pharmacovigilance System Master File.
  2. EMA Good Pharmacovigilance Practices (GVP) Module I – Pharmacovigilance Systems and Their Quality Systems.
  3. EMA Good Pharmacovigilance Practices (GVP) Module III – Pharmacovigilance Inspections.
  4. Regulation (EC) No 726/2004.
  5. Directive 2001/83/EC.
  6. Commission Implementing Regulation (EU) No 520/2012.
  7. EMA Questions and Answers on Pharmacovigilance System Master Files.

Last reviewed: 2026-06-11